1. Home
  2. JBGS vs ARDX Comparison

JBGS vs ARDX Comparison

Compare JBGS & ARDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo JBG SMITH Properties

JBGS

JBG SMITH Properties

HOLD

Current Price

$10.53

Market Cap

823.7M

Sector

Real Estate

ML Signal

HOLD

Logo Ardelyx Inc.

ARDX

Ardelyx Inc.

HOLD

Current Price

$3.42

Market Cap

975.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JBGS
ARDX
Founded
2016
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
823.7M
975.9M
IPO Year
2017
2014

Fundamental Metrics

Financial Performance
Metric
JBGS
ARDX
Price
$10.53
$3.42
Analyst Decision
Sell
Strong Buy
Analyst Count
1
7
Target Price
$15.00
★ $15.14
AVG Volume (30 Days)
801.0K
★ 3.9M
Earning Date
05-05-2026
04-30-2026
Dividend Yield
★ 4.69%
N/A
EPS Growth
★ N/A
N/A
EPS
N/A
★ N/A
Revenue
★ $498,598,000.00
$2,607,000.00
Revenue This Year
N/A
$37.75
Revenue Next Year
N/A
$34.24
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$10.41
$3.33
52 Week High
$22.38
$8.40

Technical Indicators

Market Signals
Indicator
JBGS
ARDX
Relative Strength Index (RSI) 30.51 33.22
Support Level N/A $3.33
Resistance Level $11.55 $3.92
Average True Range (ATR) 0.33 0.13
MACD -0.04 0.03
Stochastic Oscillator 17.02 18.80

Price Performance

Historical Comparison
JBGS
ARDX

About JBGS JBG SMITH Properties

JBG SMITH Properties is a real estate investment trust based in the United States. It owns, operates, invests in, and develops real estate assets concentrated in amenity-rich, metro-served submarkets in and around Washington, DC. In addition, the company also provides fee-based real estate services to legacy funds through its third-party real estate services business. The operating segments of the company are commercial, multifamily, and third-party real estate services. It generates maximum revenue from the commercial segment.

About ARDX Ardelyx Inc.

Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. Its products Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.

Share on Social Networks: